Table 3.

Relation of age, sex, GPs’ judgement of vulnerability, and severity of cardiovascular disease with optimal¹ prescription rates of cardiovascular preventive treatment in participants with a history of cardiovascular disease from the ISCOPE study (n = 1350).

Age ≥ 85 years		Female sex		Vulnerable2		Minor CVD3
OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI
Univariate	0.37	0.29–0.48	0.63	0.50–0.78	0.79	0.62–0.99	0.65	0.53–0.81
Multivariate4	0.39	0.30–0.50	0.71	0.57–0.89	0.88	0.69–1.1	0.67	0.53–0.83

CVD: cardiovascular disease. ¹Both lipid lowering and antithrombotic drug; ²patient considered vulnerable by their GP, 12 missing values; ³history of angina, transient ischaemic attack, or claudication without arterial surgery; ⁴adjusted for age, gender, vulnerability, and disease severity.